Fhm Vi, L.l.c. - Net Worth and Insider Trading

Fhm Vi, L.l.c. Net Worth

The estimated net worth of Fhm Vi, L.l.c. is at least $0 dollars as of 2024-12-13. Fhm Vi, L.l.c. is the 10% Owner of Allena Pharmaceuticals Inc and owns about 3,330,373 shares of Allena Pharmaceuticals Inc (ALNAQ) stock worth over $0. Details can be seen in Fhm Vi, L.l.c.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fhm Vi, L.l.c. has not made any transactions after 2017-11-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Fhm Vi, L.l.c.

To

Fhm Vi, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Fhm Vi, L.l.c. owns 6 companies in total, including Millendo Therapeutics Inc (MLND) , Allena Pharmaceuticals Inc (ALNAQ) , and Sierra Oncology Inc (SRRA) among others .

Click here to see the complete history of Fhm Vi, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Fhm Vi, L.l.c.

Ticker Comapny Transaction Date Type of Owner
MLND Millendo Therapeutics Inc 2018-12-07 10 percent owner
ALNAQ Allena Pharmaceuticals Inc 2017-11-06 10 percent owner
SRRA Sierra Oncology Inc 2017-02-14 10 percent owner
LIMIT LIMIT 2015-05-06 10 percent owner
LIMIT LIMIT 2009-10-05 10 percent owner
LIMIT LIMIT 2018-12-07 10 percent owner

Fhm Vi, L.l.c. Latest Holdings Summary

Fhm Vi, L.l.c. currently owns a total of 1 stock. Fhm Vi, L.l.c. owns 3,330,373 shares of Allena Pharmaceuticals Inc (ALNAQ) as of November 6, 2017, with a value of $0.

Latest Holdings of Fhm Vi, L.l.c.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALNAQ Allena Pharmaceuticals Inc 2017-11-06 3,330,373 0.00 0

Holding Weightings of Fhm Vi, L.l.c.


Fhm Vi, L.l.c. Form 4 Trading Tracker

According to the SEC Form 4 filings, Fhm Vi, L.l.c. has made a total of 0 transactions in Allena Pharmaceuticals Inc (ALNAQ) over the past 5 years. The most-recent trade in Allena Pharmaceuticals Inc is the acquisition of 500,000 shares on November 6, 2017, which cost Fhm Vi, L.l.c. around $7 Million.

Insider Trading History of Fhm Vi, L.l.c.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Fhm Vi, L.l.c. Trading Performance

GuruFocus tracks the stock performance after each of Fhm Vi, L.l.c.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fhm Vi, L.l.c. is -24.24%. GuruFocus also compares Fhm Vi, L.l.c.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Fhm Vi, L.l.c. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Fhm Vi, L.l.c.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Fhm Vi, L.l.c.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 39.5 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 38.03 LIMIT LIMIT LIMIT LIMIT LIMIT

Fhm Vi, L.l.c. Ownership Network

Ownership Network List of Fhm Vi, L.l.c.

No Data

Ownership Network Relation of Fhm Vi, L.l.c.

Insider Network Chart

Fhm Vi, L.l.c. Owned Company Details

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Fhm Vi, L.l.c. is the 10 percent owner of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include General Counsel and Secretary Tamara L Joseph , Chief Financial Officer Arcudi Iii Louis J , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Millendo Therapeutics Inc Insider Transactions

No Available Data

Fhm Vi, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Fhm Vi, L.l.c.. You might contact Fhm Vi, L.l.c. via mailing address: 601 Union Street, Suite 3200, Seattle Wa 98101.